COVID-19 and lung cancer
Authors:
Open Access
- 1 October 2023
- journal article
- review article
- Published by Siapec Servizi Srl in Pathologica
- Vol. 115 (5) , 284-291
Abstract
COVID-19 pandemic had affected health services around the world, also reducing the diagnosis of lung cancer. On the other hand, examination of surgical specimens in patients with lung cancer and SARS-CoV-2 gave the opportunity to evidence early histologic features related to this emerging pandemic. Different prioritization of health organizations during COVID-19 pandemic resulted in a significant decline of lung cancer screening (up to 56%), delayed diagnosis (up to 30-40%) and higher advanced stage, with some exceptions (i.e., Canada). Increased use of stereotactic radiation treatments in stage I-IIA have been noticed in better-organized health systems. Surgical specimens performed for lung cancer in patients with incipient SARSCoV- 2 permitted to appreciate early histologic findings of COVID-19 with hyperplastic pneumocytes with/without fibrin exudate, alveolar macrophages/myeloid cells, perivascular T-lymphocytic infiltrate and lack of hyaline membrane. While the COVID-19 pandemic has declined the rate of lung cancer diagnosis worldwide, some institutions have significantly limited detrimental effects. Histology related to early SARS-CoV-2 infection in surgical samples for lung cancer revealed specific histologic changes. Keep readingKeywords
This publication has 48 references indexed in Scilit:
- Pulmonary pathology of early‐phase COVID‐19 pneumonia in a patient with a benign lung lesionHistopathology, 2020
- Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United StatesEmerging Infectious Diseases, 2020
- Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 PandemicJournal of Thoracic Oncology, 2020
- Coronavirus Disease 2019 in the Perioperative Period of Lung Resection: A Brief Report From a Single Thoracic Surgery Department in Wuhan, People’s Republic of ChinaJournal of Thoracic Oncology, 2020
- Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung CancerJournal of Thoracic Oncology, 2020
- Early histologic findings of pulmonary SARS-CoV-2 infection detected in a surgical specimenVirchows Archiv, 2020
- Cancer in the time of COVID-19: expert opinion on how to adapt current practiceEuropean Respiratory Journal, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Hantavirus pulmonary syndrome is distinguishable from acute interstitial pneumonia.2000
- THE PULMONARY VASCULAR-LESIONS OF THE ADULT RESPIRATORY-DISTRESS SYNDROME1983